30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

2Q14 Revenue: Mazor Robotics

$4.5MM, -27% (U.S. $3.1MM, -29%; ex-U.S. $1.4MM, -22%)

  • Recognized revenue for 4 Renaissance systems (2 U.S., 2 ex-U.S.)
  • 72 systems installed globally, used in >8,000 cases to date, placing >50,000 implants
  • Experiencing a more complex purchasing process with hospital administrators dealing with the new U.S. healthcare operating environment
  • 37 clinical sales reps, planning to add 3 more by year-end